SCHEMBL19626484

SCHEMBL19626484

CCOc1cccc(-c2csc(C)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
RECQL P46063 1/20 0.57
PRMT6 Q96LA8 1/20 0.55
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
GFER P55789 1/20 0.52
EGFR P00533 3/20 0.52
NOTUM Q6P988 1/20 0.51
CDC25A P30304 1/20 0.51
CDC25B P30305 1/20 0.51
CDC25C P30307 1/20 0.51
DUSP3 P51452 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626564 0.86 RECQL (0.55) TSHRRECQLPRMT6GFERL3MBTL1
SCHEMBL19626501 0.85 CDC25A (0.61) TSHRRECQLRAB9ASMN1; SMN2NPC1
SCHEMBL19625323 0.85 RAB9A (0.50) TSHRRAB9ASMN1; SMN2NPC1NOTUM
SCHEMBL201741 0.83 CYP19A1 (0.63) TSHRRECQLPRMT6RAB9ASMN1; SMN2
SCHEMBL3631400 0.79 FGFR1 (0.54) TSHRRAB9ASMN1; SMN2NOTUMKDM4E
SCHEMBL19626579 0.78 SCN9A (0.67) TSHRRECQLPRMT6HTTKDM4E
SCHEMBL13236927 0.77 PRMT6 (0.71) TSHRRECQLPRMT6RAB9ASMN1; SMN2
SCHEMBL12269943 0.77 BRD4 (0.51) TSHRRAB9ASMN1; SMN2NOTUMKDM4E
SCHEMBL19626604 0.77 HTT (0.53) TSHRRECQLEGFRCDC25ACDC25B
SCHEMBL13591290 0.77 HTT (0.50) TSHRRECQLPRMT6GFEREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 TSHR 1830/4885RECQL 1370/4885PRMT6 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.